Classys announced that global device sales are on track to surpass 50,000 units in 2026, with first-half exports surging 29% year-over-year. The South Korean manufacturer's growth reflects rising adoption of its RF microneedling and laser platforms in international markets, particularly Asia and emerging regions.
Devices & Tech
Classys Global Device Sales to Surpass 50,000 Units in 2026
Classys first-half exports jumped 29%, signaling strong demand for its energy-device platform.
1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
Classys first-half exports surged 29%, tracking toward 50,000 global units in 2026.
For practices, Classys's scale milestone underscores the global shift toward energy-based modalities for skin tightening, texture, and body contouring. The company's export momentum suggests competitive pricing and clinical efficacy are driving market share gains against established players like InMode and Cutera. Practices evaluating device options should note Classys's growing service infrastructure and training support in key regions. Volume growth typically correlates with improved supply-chain reliability and faster consumable replenishment—factors that reduce downtime and improve per-device ROI.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.